SBIR-STTR Award

Control cell lines for use in molecular diagnostic tests
Award last edited on: 5/17/02

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$50,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Taylor C V Herst

Company Information

Oncore Analytics Inc

4900 Fannin
Houston, TX 77004
   N/A
   N/A
   N/A
Location: Single
Congr. District: 18
County: Harris

Phase I

Contract Number: 1R43AI029779-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1990
Phase I Amount
$50,000
The specific aim is to develop human cell lines containing specific, cloned genes of the pathogenic virus, HIV, the causative agent of AIDS. Each cell line will contain only one individual gene of HIV, expressed by eukaryotic gene promoter. These cell lines will provide a non-infectious, positive control standard for such diagnostic molecular tests as Southern analysis, Northern analysis, in situ hybridization, and the Polymerase Chain Reaction (PCR). The use of molecular biology as a diagnostic tool is growing world-wide. As the inclusion of a known positive control is necessary in every test, these non-infectious cell lines would act as a standard control. Currently, infected materials from patients with AIDS act as these controls. These materials are infectious and pose a direct health hazard to the laboratory worker. By employing these control cell lines, that risk would be eliminated. AIDS is only one of the many blood-borne infectious agents. Other control cell lines, containing the individual genes of HTLV-I, Hepatitis B, and Human Papilloma Virus (HPV) could also be developed for use. The commercial application of these control cell lines is broad, as both clinical labs and research labs would find them useful as reliable standards.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----